Nanogen Inc. - NGEN- Profile

Nanogen Incorporated. The Group's principal activity is to develop products that integrate advanced microelectronics and molecular biology. These products are used in the fields of biomedical research, genomics, medical diagnostics, genetic testing, drug discovery, agriculture and environmental testing. The Group's products include the NanoChip System consisting of NanoChip Molecular Biology Workstation and the NanoChip Cartridge which enables identification and precision analysis of biological test samples containing charged molecules. Its products are marketed primarily in the United States, Europe and Mexico. The Group has collaborative alliances with Hitachi, Ltd and Aventis Inc. It released its advanced diagnostic instrument the NanoChip(R)400 in 2005. In March 2006, the Group received FDA clearance begin marketing its plasma based NT-proBNP product. It acquired the assets related to rapid cardiac immunoassay test business of Spectral Diagnostics Inc on 06-Feb-2006. Develops products that integrate advanced microelectronics and molecular biology